|
Diabetes, Vol 36, Issue 4 539-541, Copyright © 1987 by American Diabetes Association
Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice
T Koike, Y Itoh, T Ishii, I Ito, K Takabayashi, N Maruyama, H Tomioka and S Yoshida
We analyzed the surface phenotypes of infiltrated cells in pancreases of
nonobese diabetic (NOD) mice with monoclonal antibodies to mouse
lymphocytes. Most of the infiltrated cells were Thy1+ and Ly1+
T-lymphocytes, and most of them were L3T4+ helper T-lymphocyte subsets. To
elucidate the role of L3T4+ T-lymphocytes in the development of insulitis
and diabetes in NOD mice, we treated the animals with injections of
monoclonal anti-L3T4 antibody. Administration of this antibody prevented
the insulitis and diabetes in NOD mice. These results lead to conclusions
that the L3T4+ helper T-lymphocytes may play an essential role in the
pathogenesis of type I diabetes and that the manipulation of the OKT4+
(Leu3+) T-lymphocyte subset, the human homology of L3T4, with monoclonal
antibodies may provide effective therapy for human type I diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. L.-T. Chang, S.-L. Chang, Y.-M. Lee, Y.-M. Chiang, D.-Y. Chuang, H.-K. Kuo, and W.-C. Yang
Cytopiloyne, a Polyacetylenic Glucoside, Prevents Type 1 Diabetes in Nonobese Diabetic Mice
J. Immunol.,
June 1, 2007;
178(11):
6984 - 6993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Kupfer, M. L. Crawford, K. Pham, and R. G. Gill
MHC-Mismatched Islet Allografts Are Vulnerable to Autoimmune Recognition In Vivo
J. Immunol.,
August 15, 2005;
175(4):
2309 - 2316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ogawa, J. F. List, J. F. Habener, and T. Maki
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
Diabetes,
July 1, 2004;
53(7):
1700 - 1705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Judkowski, C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson
Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice
J. Immunol.,
January 15, 2001;
166(2):
908 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kanagawa, J. Shimizu, and B. A. Vaupel
Thymic and Postthymic Regulation of Diabetogenic CD8 T Cell Development in TCR Transgenic Nonobese Diabetic (NOD) Mice
J. Immunol.,
May 15, 2000;
164(10):
5466 - 5473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Poulin and K. Haskins
Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse
J. Immunol.,
March 15, 2000;
164(6):
3072 - 3078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Cantorna
Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?
Experimental Biology and Medicine,
March 1, 2000;
223(3):
230 - 233.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Dahlen, G. Hedlund, and K. Dawe
Low CD86 Expression in the Nonobese Diabetic Mouse Results in the Impairment of Both T Cell Activation and CTLA-4 Up-Regulation
J. Immunol.,
March 1, 2000;
164(5):
2444 - 2456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Lejon C. and G. Fathman
Isolation of Self Antigen-Reactive Cells from Inflamed Islets of Nonobese Diabetic Mice Using CD4high Expression as a Marker
J. Immunol.,
November 15, 1999;
163(10):
5708 - 5714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Balasa, J. D. Davies, J. Lee, A. Good, B. T. Yeung, and N. Sarvetnick
IL-10 Impacts Autoimmune Diabetes Via a CD8+ T Cell Pathway Circumventing the Requirement for CD4+ T and B Lymphocytes
J. Immunol.,
October 15, 1998;
161(8):
4420 - 4427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dahlen, K. Dawe, L. Ohlsson, and G. Hedlund
Dendritic Cells and Macrophages Are the First and Major Producers of TNF-{alpha} in Pancreatic Islets in the Nonobese Diabetic Mouse
J. Immunol.,
April 1, 1998;
160(7):
3585 - 3593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Itoh, A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, H. Iwahashi, M. Moriwaki, H. Nakajima, J. Miyagawa, M. Namba, et al.
Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
J. Exp. Med.,
August 18, 1997;
186(4):
613 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Katz, C Benoist, and D Mathis
T helper cell subsets in insulin-dependent diabetes
Science,
May 26, 1995;
268(5214):
1185 - 1188.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J Bohme, B Schuhbaur, O Kanagawa, C Benoist, and D Mathis
MHC-linked protection from diabetes dissociated from clonal deletion of T cells
Science,
July 20, 1990;
249(4966):
293 - 295.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shizuru, C Taylor-Edwards, B. Banks, A. Gregory, and C. Fathman
Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes
Science,
April 29, 1988;
240(4852):
659 - 662.
[Abstract]
[PDF]
|
 |
|
Copyright © 1987 by the American Diabetes Association.
|
|
| |
|